BioPharmXCorporation (NYSE American: BPMX) (“BioPharmX“) is urging its stockholders to vote now on the proposed merger of BioPharmX with Timber Pharmaceuticals LLC (“Timber”) and related matters as described in the proxy statement/prospectus.
“We encourage all of our stockholders to review the proxy statement which you should have already received and vote your shares today,” said BioPharmX CEO Steven M. Bosacki. “The board recommends you vote in favor of the proposals.”
How to Vote
BioPharmX stockholders of record should follow the instructions on their proxy card to vote. They may call proxy solicitor Alliance Advisors toll-free at (833) 782-7191 to vote over the phone, or by following the instructions in the proxy card previously delivered to them, they may vote online or by completing, signing and dating the proxy card and mailing it in the postage-paid envelope that was previously provided.
BioPharmX stockholders who hold their shares in a brokerage or bank account (in “street name”) may vote online or by phone, by following the instructions provided in the voting instruction form previously delivered to them, or by completing, signing and dating the voting instruction form and mailing it in the postage-paid envelope that was previously provided.
Want to publish your own articles on DistilINFO Publications?
Send us an email, we will get in touch with you.
Source: BioSpace
